EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Application Research of Targeted Next-Generation Sequencing Technology Based on Bronchoalveolar Lavage Fluid in the Diagnosis of Pulmonary Tuberculosis and Drug-Resistance Detection

Chun-Yan Zhao, Chang Song, Xue-Wen Huang iD, Ai-Chun Huang, Chun-Mei Zeng, Wei-Wen Li, Qiu-Qing Tan, Xiao-Shi Lin, Zhen-Tao Huang, Chang-Yue Jiang, Qing-Dong Zhu

Infection and Drug Resistance · 2026-01 · Volume 19 · 1-14

DOI: 10.2147/idr.s567798 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Drug Resistance, 2026-01. Verfasst von Chun-Yan Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tuberculosis, The Fourth People's Hospital of Nanning, Nanning, Guangxi, 530023, People's Republic of China. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the clinical value of targeted next-generation sequencing (tNGS) using bronchoalveolar lavage fluid (BALF) in diagnosing pulmonary tuberculosis (PTB) and detecting resistance to first-line anti-tuberculosis drugs, and to compare its performance with traditional methods. Patients and Methods: In this study, BALF samples were collected from 258 patients with suspected PTB and subjected to AFB staining, mycobacterial solid culture, TB-DNA PCR, Xpert MTB/RIF, and tNGS. Using comprehensive clinical diagnosis or phenotypic DST as the reference, we evaluated the sensitivity, specificity, and other metrics of each method and assessed tNGS performance in detecting resistance to rifampicin, isoniazid, streptomycin, and ethambutol.

Results

Overall, tNGS achieved a sensitivity of 91.10%, specificity of 89.70%, and an AUC of 0.904, all significantly higher than traditional methods. It uniquely identified 24 positive cases missed by other methods. In smear-negative patients, sensitivity remained high at 88.10%, with an AUC of 0.891. For drug-resistance detection, tNGS showed the best performance in judging isoniazid resistance (sensitivity 83.10%, specificity 90.30%), and also showed high negative predictive values for rifampicin, streptomycin, and ethambutol (all > 94%). Conclusion: tNGS provides excellent diagnostic accuracy for PTB and reliable detection of drug-resistant mutations from BALF samples. It is particularly suitable for smear-negative cases and for resistance screening, making it a powerful complement to the existing TB diagnosis system with high clinical application potential.

Schlagwörter

Stichwörter der Autor:innen

bronchoalveolar lavagediagnostic efficacydrug resistancetargeted next-generation sequencingtuberculosis

Autor:innen und Institutionen

  • Department of Tuberculosis, The Fourth People's Hospital of Nanning, Nanning, Guangxi, 530023, People's Republic of China.
  • Clinical Medical School, Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China.
  • Department of Pharmacy, The Fourth People's Hospital of Nanning, Nanning, Guangxi, 530023, People's Republic of China.

ORCID-Profile: Xue-Wen Huang

Zitieren

APA

Zhao, C. Y., Song, C., Huang, X. W., Huang, A. C., Zeng, C. M., Li, W. W., Tan, Q. Q., Lin, X. S., Huang, Z. T., Jiang, C. Y., & Zhu, Q. D. (2026). Application Research of Targeted Next-Generation Sequencing Technology Based on Bronchoalveolar Lavage Fluid in the Diagnosis of Pulmonary Tuberculosis and Drug-Resistance Detection. Infection and Drug Resistance, Volume 19, 1-14. https://doi.org/10.2147/idr.s567798

Vancouver

Zhao CY, Song C, Huang XW, Huang AC, Zeng CM, Li WW, et al. Application Research of Targeted Next-Generation Sequencing Technology Based on Bronchoalveolar Lavage Fluid in the Diagnosis of Pulmonary Tuberculosis and Drug-Resistance Detection. Infection and Drug Resistance. 2026;Volume 19:1-14. doi:10.2147/idr.s567798

BibTeX
@article{Zhao2026,
  author = {Zhao, Chun-Yan and Song, Chang and Huang, Xue-Wen and Huang, Ai-Chun and Zeng, Chun-Mei and Li, Wei-Wen and Tan, Qiu-Qing and Lin, Xiao-Shi and Huang, Zhen-Tao and Jiang, Chang-Yue and Zhu, Qing-Dong},
  title = {Application Research of Targeted Next-Generation Sequencing Technology Based on Bronchoalveolar Lavage Fluid in the Diagnosis of Pulmonary Tuberculosis and Drug-Resistance Detection},
  journal = {Infection and Drug Resistance},
  year = {2026},
  volume = {Volume 19},
  pages = {1--14},
  doi = {10.2147/idr.s567798}
}
Kostenlos starten →